Abstract
Prostate-specific antigen (PSA) blood test followed by a biopsy can be used to detect prostate cancers. Both NCCN and Chinese guidelines recommend beginning PSA screening for men aged 50 or aged 45 with a family history because those populations were at a higher risk of developing prostate cancer. This study thus aimed to conduct an economic evaluation by analyzing the cost-effectiveness of PSA-based prostate cancer screening in China.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
